A detailed history of Bellevue Group Ag transactions in Omnicell, Inc stock. As of the latest transaction made, Bellevue Group Ag holds 235,372 shares of OMCL stock, worth $6.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
235,372
Previous 223,816 5.16%
Holding current value
$6.3 Million
Previous $8.42 Million 18.32%
% of portfolio
0.11%
Previous 0.13%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$26.15 - $37.33 $302,189 - $431,385
11,556 Added 5.16%
235,372 $6.88 Million
Q4 2023

Feb 14, 2024

SELL
$29.24 - $45.81 $452,138 - $708,360
-15,463 Reduced 6.46%
223,816 $8.42 Million
Q3 2023

Nov 14, 2023

SELL
$44.6 - $73.38 $2.41 Million - $3.97 Million
-54,066 Reduced 18.43%
239,279 $10.8 Million
Q2 2023

Aug 14, 2023

SELL
$57.88 - $75.94 $9.84 Million - $12.9 Million
-170,022 Reduced 36.69%
293,345 $21.6 Million
Q1 2023

May 15, 2023

SELL
$51.51 - $60.43 $2.83 Million - $3.32 Million
-55,017 Reduced 10.61%
463,367 $27.2 Million
Q4 2022

Feb 14, 2023

BUY
$46.24 - $76.09 $4.81 Million - $7.92 Million
104,100 Added 25.13%
518,384 $26.1 Million
Q3 2022

Nov 14, 2022

SELL
$86.3 - $117.38 $995,815 - $1.35 Million
-11,539 Reduced 2.71%
414,284 $36.1 Million
Q2 2022

Aug 11, 2022

BUY
$105.64 - $129.11 $6.71 Million - $8.2 Million
63,491 Added 17.52%
425,823 $48.4 Million
Q4 2021

Feb 10, 2022

SELL
$153.26 - $183.62 $4.79 Million - $5.74 Million
-31,251 Reduced 7.94%
362,332 $65.4 Million
Q2 2021

Aug 12, 2021

BUY
$129.91 - $151.45 $8.53 Million - $9.94 Million
65,664 Added 20.02%
393,583 $59.6 Million
Q1 2021

May 12, 2021

BUY
$117.78 - $143.9 $3.72 Million - $4.55 Million
31,616 Added 10.67%
327,919 $42.6 Million
Q4 2020

Feb 16, 2021

BUY
$73.85 - $120.02 $1.32 Million - $2.15 Million
17,882 Added 6.42%
296,303 $35.6 Million
Q3 2020

Nov 16, 2020

BUY
$63.15 - $77.12 $4.82 Million - $5.88 Million
76,290 Added 37.74%
278,421 $20.8 Million
Q2 2020

Aug 13, 2020

BUY
$59.36 - $74.43 $355,863 - $446,207
5,995 Added 3.06%
202,131 $14.3 Million
Q1 2020

May 14, 2020

SELL
$55.41 - $90.19 $11,248 - $18,308
-203 Reduced 0.1%
196,136 $12.9 Million
Q4 2019

Feb 14, 2020

BUY
$70.15 - $83.11 $1.73 Million - $2.05 Million
24,693 Added 14.39%
196,339 $16 Million
Q3 2019

Nov 14, 2019

BUY
$68.36 - $88.34 $337,083 - $435,604
4,931 Added 2.96%
171,646 $12.4 Million
Q2 2019

Aug 14, 2019

BUY
$71.38 - $92.21 $1.63 Million - $2.11 Million
22,876 Added 15.9%
166,715 $14.3 Million
Q1 2019

May 15, 2019

BUY
$58.88 - $86.19 $2.11 Million - $3.09 Million
35,797 Added 33.13%
143,839 $11.6 Million
Q4 2018

Feb 12, 2019

BUY
$56.97 - $77.23 $193,242 - $261,964
3,392 Added 3.24%
108,042 $6.62 Million
Q3 2018

Nov 13, 2018

BUY
$52.65 - $71.9 $2.14 Million - $2.93 Million
40,705 Added 63.66%
104,650 $7.52 Million
Q2 2018

Aug 07, 2018

BUY
$42.2 - $53.05 $1.85 Million - $2.33 Million
43,945 Added 219.73%
63,945 $3.35 Million
Q4 2017

Feb 14, 2018

BUY
$45.3 - $54.5 $906,000 - $1.09 Million
20,000
20,000 $970,000

Others Institutions Holding OMCL

About OMNICELL, Inc


  • Ticker OMCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 44,288,800
  • Market Cap $1.19B
  • Description
  • Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...
More about OMCL
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.